rs2075043

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_005045.4(RELN):​c.6702T>C​(p.Cys2234Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0549 in 1,613,844 control chromosomes in the GnomAD database, including 3,531 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.062 ( 428 hom., cov: 32)
Exomes 𝑓: 0.054 ( 3103 hom. )

Consequence

RELN
NM_005045.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 1.95

Publications

9 publications found
Variant links:
Genes affected
RELN (HGNC:9957): (reelin) This gene encodes a large secreted extracellular matrix protein thought to control cell-cell interactions critical for cell positioning and neuronal migration during brain development. This protein may be involved in schizophrenia, autism, bipolar disorder, major depression and in migration defects associated with temporal lobe epilepsy. Mutations of this gene are associated with autosomal recessive lissencephaly with cerebellar hypoplasia. Two transcript variants encoding distinct isoforms have been identified for this gene. Other transcript variants have been described but their full length nature has not been determined. [provided by RefSeq, Jul 2008]
RELN Gene-Disease associations (from GenCC):
  • lissencephaly with cerebellar hypoplasia
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Norman-Roberts syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P, PanelApp Australia
  • familial temporal lobe epilepsy 7
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autosomal dominant epilepsy with auditory features
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ankylosing spondylitis
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 7-103540425-A-G is Benign according to our data. Variant chr7-103540425-A-G is described in ClinVar as Benign. ClinVar VariationId is 95227.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.95 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.239 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RELNNM_005045.4 linkc.6702T>C p.Cys2234Cys synonymous_variant Exon 44 of 65 ENST00000428762.6 NP_005036.2
RELNNM_173054.3 linkc.6702T>C p.Cys2234Cys synonymous_variant Exon 44 of 64 NP_774959.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RELNENST00000428762.6 linkc.6702T>C p.Cys2234Cys synonymous_variant Exon 44 of 65 5 NM_005045.4 ENSP00000392423.1

Frequencies

GnomAD3 genomes
AF:
0.0621
AC:
9445
AN:
152106
Hom.:
429
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0509
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.0862
Gnomad ASJ
AF:
0.0692
Gnomad EAS
AF:
0.251
Gnomad SAS
AF:
0.0826
Gnomad FIN
AF:
0.0925
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0435
Gnomad OTH
AF:
0.0637
GnomAD2 exomes
AF:
0.0787
AC:
19759
AN:
251062
AF XY:
0.0763
show subpopulations
Gnomad AFR exome
AF:
0.0499
Gnomad AMR exome
AF:
0.107
Gnomad ASJ exome
AF:
0.0735
Gnomad EAS exome
AF:
0.246
Gnomad FIN exome
AF:
0.0933
Gnomad NFE exome
AF:
0.0440
Gnomad OTH exome
AF:
0.0649
GnomAD4 exome
AF:
0.0541
AC:
79103
AN:
1461620
Hom.:
3103
Cov.:
32
AF XY:
0.0543
AC XY:
39458
AN XY:
727094
show subpopulations
African (AFR)
AF:
0.0479
AC:
1605
AN:
33478
American (AMR)
AF:
0.104
AC:
4667
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0767
AC:
2005
AN:
26134
East Asian (EAS)
AF:
0.199
AC:
7902
AN:
39698
South Asian (SAS)
AF:
0.0817
AC:
7048
AN:
86258
European-Finnish (FIN)
AF:
0.0969
AC:
5163
AN:
53298
Middle Eastern (MID)
AF:
0.0328
AC:
189
AN:
5768
European-Non Finnish (NFE)
AF:
0.0420
AC:
46705
AN:
1111872
Other (OTH)
AF:
0.0632
AC:
3819
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
4022
8043
12065
16086
20108
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1902
3804
5706
7608
9510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0622
AC:
9464
AN:
152224
Hom.:
428
Cov.:
32
AF XY:
0.0652
AC XY:
4851
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.0510
AC:
2119
AN:
41562
American (AMR)
AF:
0.0864
AC:
1321
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0692
AC:
240
AN:
3470
East Asian (EAS)
AF:
0.250
AC:
1294
AN:
5166
South Asian (SAS)
AF:
0.0837
AC:
404
AN:
4824
European-Finnish (FIN)
AF:
0.0925
AC:
981
AN:
10606
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.0435
AC:
2955
AN:
67994
Other (OTH)
AF:
0.0654
AC:
138
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
434
869
1303
1738
2172
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
116
232
348
464
580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0523
Hom.:
91
Bravo
AF:
0.0610
Asia WGS
AF:
0.145
AC:
504
AN:
3478
EpiCase
AF:
0.0433
EpiControl
AF:
0.0415

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 30, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 27, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

not provided Benign:2
May 08, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Norman-Roberts syndrome;C4225327:Familial temporal lobe epilepsy 7 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Norman-Roberts syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.60
CADD
Benign
8.0
DANN
Benign
0.66
PhyloP100
2.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2075043; hg19: chr7-103180872; COSMIC: COSV59000954; COSMIC: COSV59000954; API